Fig. 1From: Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III–IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trialPatient flow in the YNF study for the intention-to-treat analysis. ADPKD autosomal dominant polycystic kidney disease, BID twice daily, TCM traditional Chinese medicine, TKV total kidney volume, YNF yinang formulationBack to article page